Andres L Deluna, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Deluna’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A93352 · Current
Licensed to practise in California · since 2005 · expires 2027-11-30 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$54,340
Medicare paid this office $54,340 for 874 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 494 | $30,040 | $58 |
| Return visit (30+ min) | 82 | $7,066 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,316 | $103 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 269 | $2,344 | $7 |
| Short return visit (20+ min) | 36 | $1,773 | $49 |
See all 11 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 494 | $30,040 | $58 |
| Return visit (30+ min) | 82 | $7,066 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,316 | $103 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 269 | $2,344 | $7 |
| Short return visit (20+ min) | 36 | $1,773 | $49 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,525 | $117 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 44 | $1,097 | $20 |
| Ultrasound of heart, follow-up | 20 | $491 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 18 | $306 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $201 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $102 | $5 |
Who their Medicare patients are
874 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 20% · Women 52% · Also on Medicaid 79% · Health risk score 2.53. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 55% · Heart failure 45% · Coronary heart disease 42% · Chronic kidney disease 38% · Atrial fibrillation 38% · Depression 25% · Dementia 24% · COPD 20% · Stroke 20% · Cancer 13%.
The office billed $701,079, Medicare allowed $74,206 and paid $54,340; for 1,241 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 874 | 1,241 | 75 | 2.53 | $701,079 | $54,340 |
| 2023 | 829 | 1,106 | 73 | 2.26 | $657,341 | $53,172 |
| 2022 | 1,005 | 1,396 | 73 | 2.08 | $673,524 | $59,367 |
| 2021 | 1,059 | 1,515 | 73 | 2.10 | $643,424 | $61,254 |
| 2020 | 915 | 1,321 | 72 | 2.59 | $540,747 | $54,169 |
| 2019 | 1,088 | 1,562 | 70 | 2.13 | $807,796 | $57,018 |
| 2018 | 1,047 | 1,440 | 71 | 2.16 | $822,295 | $49,477 |
| 2017 | 900 | 1,318 | 71 | 2.33 | $676,414 | $47,385 |
| 2016 | 596 | 822 | 71 | 2.11 | $283,884 | $37,179 |
| 2015 | 206 | 725 | 73 | 2.03 | $95,099 | $32,236 |
| 2014 | 178 | 474 | 73 | 2.03 | $82,196 | $28,910 |
| 2013 | 307 | 602 | 72 | 2.65 | $99,253 | $37,598 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 506 | $30,095 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $8,028 | $115 |
| Return visit (30+ min) | 83 | $7,277 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 207 | $1,713 | $7 |
| Short return visit (20+ min) | 31 | $1,449 | $47 |
| Ultrasound of heart, follow-up | 24 | $574 | $21 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 16 | $347 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 17 | $105 | $6 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $74 | $6 |
2022: 12 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 475 | $29,930 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $8,255 | $115 |
| Return visit (30+ min) | 55 | $4,571 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 330 | $2,832 | $7 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,683 | $103 |
| Short return visit (20+ min) | 39 | $2,125 | $54 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,077 | $99 |
| Telephone medical discussion with physician, 11-20 minutes | 42 | $1,999 | $48 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 61 | $858 | $13 |
| Ultrasound of heart, follow-up | 12 | $304 | $23 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 21 | $193 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 44 | $130 | $3 |
2021: 11 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 498 | $32,834 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $7,683 | $115 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 35 | $3,984 | $111 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 409 | $3,894 | $7 |
| Telephone medical discussion with physician, 21-30 minutes | 37 | $3,024 | $82 |
| Short return visit (20+ min) | 47 | $2,753 | $56 |
| Return visit (30+ min) | 16 | $1,441 | $90 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 78 | $1,434 | $17 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $944 | $50 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 34 | $512 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 59 | $311 | $5 |
2020: 14 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 356 | $23,108 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $6,979 | $114 |
| Telephone medical discussion with physician, 21-30 minutes | 56 | $4,094 | $72 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 39 | $4,063 | $102 |
| Return visit (30+ min) | 52 | $3,685 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 363 | $3,096 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 82 | $1,839 | $21 |
| Telephone medical discussion with physician, 11-20 minutes | 29 | $1,219 | $38 |
| Short return visit (20+ min) | 22 | $882 | $40 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $538 | $41 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $382 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 15 | $349 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 14 | $283 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 48 | $208 | $4 |
2019: 14 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 387 | $24,337 | $61 |
| Return visit (30+ min) | 105 | $9,000 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $6,235 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 426 | $3,540 | $7 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 37 | $3,088 | $83 |
| Short return visit (20+ min) | 43 | $1,818 | $41 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 79 | $1,606 | $20 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 50 | $948 | $19 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 18 | $857 | $48 |
| New patient visit (30+ min) | 14 | $608 | $43 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 92 | $457 | $5 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 16 | $419 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $328 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $220 | $13 |
2018: 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 372 | $22,873 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $5,922 | $91 |
| Return visit (30+ min) | 73 | $4,970 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 460 | $3,984 | $7 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 30 | $2,509 | $84 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 95 | $2,378 | $24 |
| Short return visit (20+ min) | 25 | $888 | $36 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 16 | $776 | $48 |
| Ultrasound of heart, follow-up | 19 | $443 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 62 | $402 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 18 | $368 | $20 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $73 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $32 | $3 |
2017: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 286 | $16,246 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $7,572 | $93 |
| Return visit (30+ min) | 78 | $7,371 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 405 | $3,624 | $7 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 35 | $3,073 | $88 |
| Short return visit (20+ min) | 42 | $1,796 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 76 | $1,559 | $21 |
| Ultrasound of heart, follow-up | 16 | $372 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 71 | $311 | $4 |
2016: 12 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 159 | $9,082 | $57 |
| Return visit (30+ min) | 48 | $4,055 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,991 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,189 | $168 |
| New patient visit (45+ min) | 18 | $2,182 | $121 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 244 | $1,981 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | $1,944 | $139 |
| Return visit (30+ min) | 27 | $1,875 | $69 |
| Short return visit (20+ min) | 38 | $1,705 | $45 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 48 | $1,154 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 25 | $345 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $85 | $6 |
2015: 9 services
| Return visit (30+ min) | 54 | $8,461 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $4,568 | $88 |
| New patient visit (45+ min) | 23 | $3,048 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,224 | $171 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | $2,184 | $156 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 16 | $974 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 80 | $627 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 40 | $556 | $14 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $214 | $14 |
2014: 8 services
| Return visit (30+ min) | 52 | $6,715 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,528 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30 | $3,397 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,412 | $172 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 17 | $928 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 13 | $707 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 65 | $622 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $322 | $15 |
2013: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $7,466 | $86 |
| Return visit (30+ min) | 56 | $6,119 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,637 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 40 | $2,780 | $68 |
| New patient visit (45+ min) | 19 | $2,432 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 157 | $1,407 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,108 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 31 | $500 | $16 |
Medicaid work
$31,242 in 2024
Medicaid paid $31,242 for 3,343 billed services this clinician did in 2024, up to 170 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 1,337 | $21,844 |
| Return visit (30+ min) | 251 | $4,101 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 773 | $3,048 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 82 | $2,060 |
| External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation | 71 | $189 |
| Pain severity quantified; no pain present (COA) (ONC) | 28 | $0 |
| Medication list documented in medical record (COA) | 261 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 64 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 143 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 80 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 253 | $0 |
| 2024 | 3,343 | 11 | 170 | $31,242 |
| 2023 | 2,933 | 11 | 196 | $28,928 |
| 2022 | 2,995 | 8 | 140 | $32,646 |
| 2021 | 3,317 | 4 | 217 | $32,738 |
| 2020 | 2,034 | 5 | 101 | $22,577 |
| 2019 | 2,675 | 10 | 131 | $21,613 |
| 2018 | 2,936 | 5 | 131 | $25,415 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 1,544 | $22,304 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 830 | $2,743 |
| Return visit (30+ min) | 279 | $1,910 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 99 | $1,377 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 48 | $282 |
| ECHO TTHRC R-T 2D W/WO M-MODE COMPLETE REST&ST | 14 | $203 |
| External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation | 14 | $89 |
| ECHO TRANSTHORC R-T 2D W/WO M-MODE REC F-UP/LMTD | 14 | $20 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 20 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 26 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 45 | $0 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 1,271 | $22,197 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,134 | $5,054 |
| XTRNL ECG REC<48 HR R&I | 212 | $1,755 |
| Return visit (30+ min) | 197 | $1,540 |
| Short return visit (20+ min) | 112 | $1,238 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 41 | $550 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 12 | $188 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 16 | $124 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 1,257 | $22,272 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,524 | $6,915 |
| Short return visit (20+ min) | 236 | $2,179 |
| XTRNL ECG REC<48 HR R&I | 300 | $1,373 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 830 | $16,182 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 948 | $4,117 |
| XTRNL ECG REC<48 HR R&I | 195 | $1,237 |
| Return visit (30+ min) | 47 | $709 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 14 | $332 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 822 | $13,854 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,207 | $4,169 |
| Return visit (30+ min) | 269 | $1,196 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 67 | $721 |
| XTRNL ECG REC<48 HR R&I | 210 | $643 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 37 | $531 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 26 | $285 |
| ECHO TTHRC R-T 2D W/WO M-MODE COMPLETE REST&ST | 13 | $104 |
| CARDIOVASCULAR STRESS TEST | 12 | $69 |
| CARDIOVASCULAR STRESS TEST | 12 | $42 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 874 | $16,827 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,544 | $5,528 |
| Return visit (30+ min) | 201 | $1,400 |
| XTRNL ECG REC<48 HR R&I | 265 | $1,027 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 52 | $632 |
Drugs they prescribed that Part D paid
$93,989
Pharmacies billed $93,989 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 649) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
544 generic and 105 brand-name prescriptions · $93,989 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 46 | $38,381 | $834 |
| Xarelto | 34 | $35,662 | $1,049 |
| Entresto | 15 | $13,203 | $880 |
| Bumetanide | 16 | $654 | $41 |
| Metoprolol | 49 | $585 | $12 |
See all 18 drugs
| Eliquis | 46 | $38,381 | $834 |
| Xarelto | 34 | $35,662 | $1,049 |
| Entresto | 15 | $13,203 | $880 |
| Bumetanide | 16 | $654 | $41 |
| Metoprolol | 49 | $585 | $12 |
| Amiodarone | 56 | $562 | $10 |
| Carvedilol | 34 | $360 | $11 |
| Atorvastatin | 57 | $275 | $5 |
| Furosemide | 50 | $225 | $4 |
| Isosorbide Mononitrate Er | 22 | $210 | $10 |
| Clopidogrel | 34 | $198 | $6 |
| Spironolactone | 24 | $163 | $7 |
| Hydralazine | 15 | $142 | $9 |
| Metoprolol | 23 | $116 | $5 |
| Pravastatin | 18 | $97 | $5 |
| Amlodipine Besylate | 36 | $82 | $2 |
| Lisinopril | 30 | $74 | $2 |
| Rosuvastatin | 13 | $41 | $3 |
Year by year
| 2024 | 649 | 117 | 0% (0) | 16% | $93,989 |
| 2023 | 556 | 115 | 0% (0) | None | $93,134 |
| 2022 | 684 | 115 | 0% (0) | 17% | $100,293 |
| 2021 | 623 | 113 | 0% (0) | 23% | $66,835 |
| 2020 | 537 | 106 | 0% (0) | 22% | $38,450 |
| 2019 | 372 | 92 | 0% (0) | 23% | $19,970 |
| 2018 | 234 | 73 | 0% (0) | 10% | $4,839 |
| 2017 | 187 | 68 | 0% (0) | 13% | $3,302 |
| 2016 | 1,219 | 229 | 0% (0) | 10% | $37,603 |
| 2015 | 1,935 | 308 | 0% (0) | 12% | $60,073 |
| 2014 | 2,254 | 354 | 0% (0) | 13% | $66,968 |
| 2013 | 1,709 | 368 | None | 9% | $46,566 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Eliquis | 43 | $39,079 | $909 |
| Xarelto | 30 | $27,418 | $914 |
| Entresto | 17 | $14,040 | $826 |
| Atorvastatin | 55 | $1,284 | $23 |
| Bumetanide | 18 | $1,097 | $61 |
| Clopidogrel | 41 | $720 | $18 |
| Metoprolol | 40 | $521 | $13 |
| Furosemide | 58 | $503 | $9 |
| Metoprolol | 26 | $498 | $19 |
| Carvedilol | 24 | $482 | $20 |
| Amiodarone | 33 | $367 | $11 |
| Simvastatin | 11 | $302 | $27 |
| Amlodipine Besylate | 19 | $288 | $15 |
| Pravastatin | 13 | $197 | $15 |
| Spironolactone | 23 | $155 | $7 |
2022: 19 drugs
| Eliquis | 48 | $40,418 | $842 |
| Xarelto | 43 | $38,432 | $894 |
| Bumetanide | 33 | $2,080 | $63 |
| Clopidogrel | 59 | $1,044 | $18 |
| Atorvastatin | 69 | $927 | $13 |
| Metoprolol | 35 | $854 | $24 |
| Furosemide | 76 | $498 | $7 |
| Metoprolol | 52 | $452 | $9 |
| Pravastatin | 16 | $370 | $23 |
| Carvedilol | 21 | $350 | $17 |
| Digoxin | 14 | $287 | $20 |
| Amiodarone | 31 | $264 | $9 |
| Amlodipine Besylate | 22 | $244 | $11 |
| Losartan | 14 | $223 | $16 |
| Isosorbide Mononitrate Er | 15 | $204 | $14 |
| Simvastatin | 16 | $114 | $7 |
| Lisinopril | 28 | $111 | $4 |
| Spironolactone | 12 | $111 | $9 |
| Hydralazine | 13 | $96 | $7 |
2021: 19 drugs
| Xarelto | 44 | $25,602 | $582 |
| Eliquis | 43 | $22,818 | $531 |
| Bumetanide | 32 | $3,436 | $107 |
| Metoprolol | 30 | $1,050 | $35 |
| Atorvastatin | 45 | $803 | $18 |
| Clopidogrel | 32 | $445 | $14 |
| Amiodarone | 38 | $443 | $12 |
| Digoxin | 15 | $354 | $24 |
| Potassium Chloride | 13 | $351 | $27 |
| Isosorbide Mononitrate Er | 17 | $315 | $19 |
| Furosemide | 70 | $309 | $4 |
| Spironolactone | 18 | $270 | $15 |
| Pravastatin | 21 | $262 | $12 |
| Amlodipine Besylate | 21 | $238 | $11 |
| Carvedilol | 26 | $214 | $8 |
| Lisinopril | 33 | $169 | $5 |
| Metoprolol | 28 | $164 | $6 |
| Losartan | 22 | $148 | $7 |
| Simvastatin | 14 | $99 | $7 |
2020: 18 drugs
| Xarelto | 20 | $11,977 | $599 |
| Eliquis | 24 | $11,208 | $467 |
| Bumetanide | 25 | $3,235 | $129 |
| Atorvastatin | 50 | $757 | $15 |
| Clopidogrel | 44 | $524 | $12 |
| Pravastatin | 22 | $384 | $17 |
| Isosorbide Mononitrate Er | 24 | $375 | $16 |
| Metoprolol | 11 | $358 | $33 |
| Amiodarone | 31 | $314 | $10 |
| Furosemide | 58 | $232 | $4 |
| Carvedilol | 31 | $232 | $7 |
| Lisinopril | 34 | $152 | $4 |
| Potassium Chloride | 11 | $119 | $11 |
| Spironolactone | 15 | $103 | $7 |
| Hydralazine | 16 | $97 | $6 |
| Losartan | 16 | $83 | $5 |
| Metoprolol | 12 | $51 | $4 |
| Warfarin | 12 | $30 | $2 |
2019: 10 drugs
| Clopidogrel | 41 | $529 | $13 |
| Carvedilol | 55 | $438 | $8 |
| Atorvastatin | 26 | $392 | $15 |
| Isosorbide Mononitrate Er | 16 | $278 | $17 |
| Furosemide | 47 | $243 | $5 |
| Pravastatin | 27 | $220 | $8 |
| Metoprolol | 16 | $127 | $8 |
| Amlodipine Besylate | 13 | $102 | $8 |
| Losartan | 15 | $83 | $6 |
| Lisinopril | 20 | $54 | $3 |
2018: 8 drugs
| Atorvastatin | 31 | $429 | $14 |
| Pravastatin | 26 | $378 | $15 |
| Clopidogrel | 34 | $371 | $11 |
| Carvedilol | 20 | $94 | $5 |
| Furosemide | 18 | $71 | $4 |
| Amiodarone | 11 | $69 | $6 |
| Lisinopril | 13 | $67 | $5 |
| Warfarin | 13 | $30 | $2 |
2017: 6 drugs
| Atorvastatin | 32 | $506 | $16 |
| Pravastatin | 19 | $358 | $19 |
| Clopidogrel | 17 | $154 | $9 |
| Carvedilol | 18 | $127 | $7 |
| Lisinopril | 23 | $94 | $4 |
| Metoprolol | 12 | $47 | $4 |
2016: 20 drugs
| Atorvastatin | 147 | $3,201 | $22 |
| Pravastatin | 103 | $2,675 | $26 |
| Carvedilol | 196 | $1,626 | $8 |
| Clopidogrel | 78 | $1,347 | $17 |
| Diltiazem 24hr Er | 12 | $1,118 | $93 |
| Metoprolol | 34 | $996 | $29 |
| Amlodipine Besylate | 101 | $867 | $9 |
| Metoprolol | 97 | $788 | $8 |
| Digox | 16 | $779 | $49 |
| Hydralazine | 43 | $768 | $18 |
| Isosorbide Mononitrate Er | 37 | $637 | $17 |
| Digoxin | 11 | $588 | $53 |
| Lisinopril | 87 | $530 | $6 |
| Losartan | 40 | $502 | $13 |
| Nitrostat | 11 | $419 | $38 |
| Potassium Chloride | 11 | $411 | $37 |
| Furosemide | 51 | $316 | $6 |
| Amiodarone | 23 | $205 | $9 |
| Spironolactone | 18 | $128 | $7 |
| Benazepril | 12 | $59 | $5 |
2015: 23 drugs
| Pravastatin | 227 | $6,651 | $29 |
| Atorvastatin | 232 | $5,601 | $24 |
| Crestor | 19 | $4,474 | $235 |
| Carvedilol | 349 | $3,256 | $9 |
| Clopidogrel | 90 | $1,686 | $19 |
| Digox | 19 | $1,606 | $85 |
| Hydralazine | 54 | $1,401 | $26 |
| Amlodipine Besylate | 179 | $1,276 | $7 |
| Metoprolol | 141 | $1,105 | $8 |
| Lisinopril | 136 | $1,052 | $8 |
| Potassium Chloride | 29 | $1,023 | $35 |
| Isosorbide Mononitrate Er | 39 | $905 | $23 |
| Metoprolol | 35 | $904 | $26 |
| Losartan | 63 | $863 | $14 |
| Amiodarone | 37 | $648 | $18 |
| Furosemide | 77 | $523 | $7 |
| Diltiazem Er | 11 | $457 | $42 |
| Nitrostat | 21 | $450 | $21 |
| Doxazosin Mesylate | 13 | $313 | $24 |
| Benazepril | 36 | $229 | $6 |
| Clonidine | 15 | $186 | $12 |
| Spironolactone | 17 | $91 | $5 |
| Hydrochlorothiazide | 11 | $69 | $6 |
2014: 21 drugs
| Pravastatin | 366 | $10,169 | $28 |
| Carvedilol | 508 | $6,113 | $12 |
| Atorvastatin | 236 | $5,875 | $25 |
| Diltiazem 24hr Er | 14 | $2,592 | $185 |
| Amlodipine Besylate | 227 | $2,214 | $10 |
| Hydralazine | 76 | $2,082 | $27 |
| Clopidogrel | 70 | $1,794 | $26 |
| Isosorbide Mononitrate Er | 39 | $1,091 | $28 |
| Lisinopril | 122 | $1,046 | $9 |
| Metoprolol | 116 | $996 | $9 |
| Nitrostat | 55 | $936 | $17 |
| Doxazosin Mesylate | 13 | $830 | $64 |
| Metoprolol | 21 | $743 | $35 |
| Amiodarone | 16 | $719 | $45 |
| Losartan | 42 | $599 | $14 |
| Potassium Chloride | 24 | $586 | $24 |
| Furosemide | 71 | $498 | $7 |
| Benazepril | 33 | $338 | $10 |
| Bumetanide | 11 | $274 | $25 |
| Hydrochlorothiazide | 20 | $141 | $7 |
| Warfarin | 12 | $41 | $3 |
2013: 20 drugs
| Pravastatin | 385 | $9,482 | $25 |
| Carvedilol | 379 | $6,953 | $18 |
| Diltiazem 24hr Er | 17 | $2,114 | $124 |
| Atorvastatin | 59 | $1,969 | $33 |
| Clopidogrel | 62 | $1,934 | $31 |
| Amlodipine Besylate | 128 | $1,812 | $14 |
| Lisinopril | 151 | $1,520 | $10 |
| Metoprolol | 27 | $1,139 | $42 |
| Metoprolol | 79 | $933 | $12 |
| Losartan | 45 | $923 | $21 |
| Isosorbide Mononitrate Er | 34 | $848 | $25 |
| Hydralazine | 28 | $819 | $29 |
| Potassium Chloride | 18 | $464 | $26 |
| Nitrostat | 29 | $328 | $11 |
| Amiodarone | 17 | $322 | $19 |
| Furosemide | 48 | $291 | $6 |
| Simvastatin | 11 | $215 | $20 |
| Benazepril | 19 | $201 | $11 |
| Lovastatin | 15 | $190 | $13 |
| Hydrochlorothiazide | 27 | $187 | $7 |
Professional record
- NPI
- 1881728426
- Licence
- CA A93352California A93352: Current · expires 2027-11-30
- Trained
- University of California, Geffen School of Medicine, 2004
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 3080 Bristol St, Suite 600, Costa Mesa, CA, 92626
- NPI first listed
- 2007-03-15
- NPI last updated
- 2014-10-23
This is when the NPI record was last certified, not a medical board exam.